Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial

Completed

Conditions: Ankylosing Spondylitis

First Posted Date: 2013-02-15

Last Posted Date: 2013-02-15

Lead Sponsor: Pfizer

Target Recruit Count: 85

Registration Number: NCT01793285

Locations: 🇪🇸
Pfizer Investigational Site, Valencia, Spain

Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -

Completed

Conditions: Peritonitis
Pneumonia
Lung Abscess

Interventions: Drug: Sulbactam Sodium/Ampicillin Sodium

First Posted Date: 2013-02-15

Last Posted Date: 2017-04-26

Lead Sponsor: Pfizer

Target Recruit Count: 982

Registration Number: NCT01793688

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

Phase 2

Terminated

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: PF-05175157
Drug: Placebo

First Posted Date: 2013-02-15

Last Posted Date: 2017-02-16

Lead Sponsor: Pfizer

Target Recruit Count: 19

Registration Number: NCT01792635

Locations: 🇺🇸
Profil Institute for Clinical Research, Inc., Chula Vista, California, United States

Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A

Completed

Conditions: Hemophilia A

First Posted Date: 2013-02-13

Last Posted Date: 2015-08-17

Lead Sponsor: Pfizer

Target Recruit Count: 42

Registration Number: NCT01790828

Locations: 🇰🇷
Yonsei Rehabilitation Clinic, Guro-gu, Seoul, Korea, Republic of
🇰🇷
Pusan National University Hospital, Busan, Korea, Republic of
🇰🇷
Kim Hugh Chul Internal Medicine Clinic, Songpa-gu, Seoul, Korea, Republic of

and more 1 locations

A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

Phase 1

Completed

Conditions: Pharmacokinetics
Open Label
CXL
Effect on Intestinal Flora
CAZ-AVI
Safety

Interventions: Drug: CAZ-AVI
Drug: CXL

First Posted Date: 2013-02-12

Last Posted Date: 2017-09-05

Lead Sponsor: Pfizer

Target Recruit Count: 48

Registration Number: NCT01789528

Locations: 🇸🇪
Research Site, Stockholm, Sweden

Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet

Phase 3

Completed

Conditions: Analgesia

Interventions: Drug: Ibuprofen 600 mg Immediate Release/Extended Release Caplet

First Posted Date: 2013-02-12

Last Posted Date: 2017-08-28

Lead Sponsor: Pfizer

Target Recruit Count: 1083

Registration Number: NCT01789606

Locations: 🇺🇸
Family Plaza Pharmacy, West Jordan, Utah, United States
🇺🇸
Goodrich Pharmacy, Blaine, Minnesota, United States
🇺🇸
B and B Pharmacy, Yorba Linda, California, United States

and more 14 locations

Tygacil Drug Use Investigation

Completed

Conditions: Intra-Abdominal Infections
Skin Disease, Infectious

Interventions: Drug: Tigecycline (Tygacil)

First Posted Date: 2013-02-12

Last Posted Date: 2019-02-06

Lead Sponsor: Pfizer

Target Recruit Count: 116

Registration Number: NCT01789905

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

Phase 2

Completed

Conditions: Ankylosing Spondylitis

Interventions: Drug: Tofacitinib 2 mg
Drug: Tofacitinib 5 mg
Drug: Tofacitinib 10 mg
Drug: Placebo

First Posted Date: 2013-02-08

Last Posted Date: 2016-06-10

Lead Sponsor: Pfizer

Target Recruit Count: 208

Registration Number: NCT01786668

Locations: 🇨🇿
Medical Plus, Uherske Hradiste, Czech Republic
🇰🇷
Chonnam National University Hospital, Gwangju, Korea, Republic of
🇵🇱
Twoja Przychodnia - Centrum Medyczne Nowa Sol, Nowa Sol, Poland

and more 64 locations

Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

Terminated

Conditions: Back Pain

Interventions: Other: Control cohort
Other: painPREMIER cohort

First Posted Date: 2013-02-08

Last Posted Date: 2016-04-06

Lead Sponsor: Pfizer

Target Recruit Count: 86

Registration Number: NCT01787565

Locations: 🇫🇮
Pfizer Investigational Site, Helsinki, Finland

RIPT of Ibuprofen Topical Gel

Phase 1

Completed

Conditions: Pain

Interventions: Drug: Sodium chloride solution 0.9% (saline)
Drug: Topical gel vehicle
Drug: Sodium lauryl sulfate 0.1%

First Posted Date: 2013-02-08

Last Posted Date: 2013-02-28

Lead Sponsor: Pfizer

Target Recruit Count: 234

Registration Number: NCT01787448

Locations: 🇺🇸
Pfizer Investigational Site, Carlstadt, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy